Search
Home
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Great Place To Work
Analytics
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Home
Latest
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Rankings
Great Place To Work
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Sy Mukherjee
Sy Mukherjee is a former health care reporter for
Fortune.
Page 17 of 100
Health
There’s been a strange fluctuation in the health care job market during the pandemic
By
Sy Mukherjee
Health
Rumors swirl about an AstraZeneca and Gilead megadeal—but it doesn’t make sense
By
Sy Mukherjee
Newsletters
The health care system is stacked against black lives
By
Sy Mukherjee
Health
5 companies to keep an eye on following the world’s largest cancer conference
By
Sy Mukherjee
Newsletters
Getting back to the office in the midst of coronavirus is going to be complicated
By
Sy Mukherjee
Health
The CDC says antibody tests shouldn’t be used to make return-to-work decisions
By
Sy Mukherjee
Newsletters
Moderna’s coronavirus vaccine expectations game
By
Sy Mukherjee
Health
The health care industry’s winners and losers in the midst of the pandemic
By
Sy Mukherjee
Health
Tobacco giants are getting into the coronavirus vaccine race
By
Sy Mukherjee
Health
Moderna releases promising—but early—new coronavirus vaccine data
By
Sy Mukherjee
Newsletters
Antibody testing’s chicken and egg problem
By
Sy Mukherjee
Politics
4 takeaways from the House Democrats’ new $3 trillion stimulus bill
By
Nicole Goodkind
and
Sy Mukherjee
Health
Antibody testing will be key—once we understand what the results mean
By
Sy Mukherjee
Newsletters
Gilead’s moral (and financial) COVID-19 conundrum
By
Sy Mukherjee
Health
Remdesivir is the first coronavirus treatment. So why is Gilead’s stock plunging?
By
Sy Mukherjee